Neuromuscular scoliosis (NMS), Adolescent idiopathic scoliosis (AIS)
Conditions
Brief summary
Primary outcome is the intraoperative blood loss (blood loss in mL after wound closure).
Detailed description
Secondary outcomes include need for allogenic red blood cell infusion (percentage of patients at hospital release, health-related quality of life (Scoliosis Research Society 24 outcome questionnaire), postoperative pain (48-hour opioid consumption, pain visual analogue score), operative time (hours), drain output (mL), hidden blood loss (mL), hospital stay, and complications (skin reactions, TRALI, deep surgical site infection).
Interventions
DRUGPlasma-Lyte® 148 (pH 7.4) solution for infusion.
DRUGoctaplasLG infuusiokuiva-aine ja liuotin
DRUGliuosta varten
Sponsors
HUS-Yhtymae
Eligibility
Sex/Gender
All
Age
0 Years to 64 Years
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary outcome is the intraoperative blood loss (blood loss in mL after wound closure). | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcomes include need for allogenic red blood cell infusion (percentage of patients at hospital release, health-related quality of life (Scoliosis Research Society 24 outcome questionnaire), postoperative pain (48-hour opioid consumption, pain visual analogue score), operative time (hours), drain output (mL), hidden blood loss (mL), hospital stay, and complications (skin reactions, TRALI, deep surgical site infection). | — |
Countries
Finland
Outcome results
None listed